Cardiovascular implantable electronic devices (CIEDs) have expanded in number and complexity since their introduction in 1958 and now include cardiac pacemakers, implantable cardioverter-defibrillators (ICD), implantable cardiovascular monitors and implantable loop recorders. Distinctions are not always complete; bradycardia support, ventricular tachyarrhythmia therapy, biventricular stimulation, arrhythmia monitoring, and heart failure data are often combined into a single device. Many aspects of CIED monitoring are discussed in this document, including, monitoring technology; indications, frequency and content of device follow-up; data management; personnel roles and responsibilities; CIED management in dying patients; and reimbursement issues. However, beyond listing the required elements, it is beyond the scope of this document to describe the technical details used during each type of CIED follow-up visit.

HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIED): Description of Techniques, Indications, Personnel, Frequency and Ethical Considerations.

PRIORI, SILVIA GIULIANA;
2008-01-01

Abstract

Cardiovascular implantable electronic devices (CIEDs) have expanded in number and complexity since their introduction in 1958 and now include cardiac pacemakers, implantable cardioverter-defibrillators (ICD), implantable cardiovascular monitors and implantable loop recorders. Distinctions are not always complete; bradycardia support, ventricular tachyarrhythmia therapy, biventricular stimulation, arrhythmia monitoring, and heart failure data are often combined into a single device. Many aspects of CIED monitoring are discussed in this document, including, monitoring technology; indications, frequency and content of device follow-up; data management; personnel roles and responsibilities; CIED management in dying patients; and reimbursement issues. However, beyond listing the required elements, it is beyond the scope of this document to describe the technical details used during each type of CIED follow-up visit.
2008
Cardiovascular & Hematology Research covers all levels of investigation into the normal and pathogenic functions of the heart, vasculature, and soluble blood components. Cell biology of vascular tissue and formed elements of blood, biochemical regulation of thrombosis, therapeutic strategies for treatment of cardiac and vascular diseases are also considered. Resources on hematologic oncology are excluded and are placed in the Oncogenesis & Cancer Research category.
Sì, ma tipo non specificato
Inglese
Internazionale
STAMPA
10
6
707
725
Monitoring of Cardiovascular Implantable Electronic Devices (CIED); HRS/EHRA; Expert Consensus
15
info:eu-repo/semantics/article
262
Wilkoff, Bl; Auricchio, A; Brugada, J; Cowie, M; Ellenbogen, Ka; Gillis, Am; Hayes, Dl; Howlett, Jg; Kautzner, J; Love, Cj; Morgan, Jm; Priori, SILVIA...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
none
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/143152
Citazioni
  • ???jsp.display-item.citation.pmc??? 70
  • Scopus 247
  • ???jsp.display-item.citation.isi??? 238
social impact